Previous 10 | Next 10 |
Aerovate Therapeutics (NASDAQ:AVTE): Q3 GAAP EPS of -$0.26 in-line. Cash and cash equivalents of $180.87M Shares -10.24%. Press Release For further details see: Aerovate Therapeutics EPS in-line
WALTHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced our financial results f...
Gainers: Camber Energy (NYSE:CEI) +27%. HCW Biologics (NASDAQ:HCWB) +21%. Fuel Tech (NASDAQ:FTEK) +23%. RedHill (NASDAQ:RDHL) +19%. Harmony (NASDAQ:HRMY) +15%. Ginkgo Bioworks (NYSE:DNA) +15%. Arqit Quantum (NASDAQ:ARQQ) +14%. AlloVir (NASDAQ:ALVR) +13%. ViewRay (NASDAQ:VRAY) +13%. Full Truck...
Gainers: AlloVir (NASDAQ:ALVR) +14%, InflaRx (NASDAQ:IFRX) +14%, Harmony Biosciences (NASDAQ:HRMY) +13%, Omeros (NASDAQ:OMER) +11%, Prelude Therapeutics (NASDAQ:PRLD) +11%. Losers: Galera Therapeutics (NASDAQ:GRTX) -68%, Atea Pharmaceutic...
Gainers: ION Geophysical (NYSE:IO) +42%. Valneva (NASDAQ:VALN) +33%. Progenity (NASDAQ:PROG) +31%. MeiraGTx (NASDAQ:MGTX) +30%. BTCS (NASDAQ:BTCS) +22%. Peabody Energy (NYSE:BTU) +20%. Evolving Systems (NASDAQ:EVOL) +18%. InMed (NASDAQ:INM) +16%. TORM (NASDAQ:TRMD) +17%. Aerovate (NASDAQ:AVTE...
Gainers: Valneva SE VALN +33%, MeiraGTx (NASDAQ:MGTX) +22%, Adamis Pharmaceuticals ADMP +20%, Aerovate Therapeutics AVTE +18%, Progenity (NASDAQ:PROG) +16%. Losers: Revance Therapeutics RVNC -42%, Omeros OMER -25%, MannKind MNKD...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P 500 wrapped up its best week since July, closing at its highest level in a month, as a series of upside earnings reports from Wal...
Gainers: LM Funding America (NASDAQ:LMFA) +37%. Xiaobai Maimai (NASDAQ:HX) +22%. 23andMe Holding ME +21%. Nxt-ID NXTD +20%. P.A.M. Transportation Services PTSI +20%. Statera Biopharma (NASDAQ:STAB) +18%. Alcoa AA +17%. Hut 8 Mining HUT +16%. Jasper Therapeutics JSPR...
Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...
One of today's stocks on the move is Aerovate Therapeutics Inc. (NSD:AVTE), down 29.6% to $14.52. In the past 52 weeks, shares of Aerovate Therapeutics Inc. have traded between a low of $11.40 and a high of $29.43 and is now at $14.52, which is 27% above that low price. Receive IBN Spo...
News, Short Squeeze, Breakout and More Instantly...
Aerovate Therapeutics Inc. Company Name:
AVTE Stock Symbol:
NASDAQ Market:
Aerovate Therapeutics Inc. Website:
WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), which previously announced it was halting enrollment and shutting down the Phase 3 portion of the I nhaled i M atinib P ulmonary A rterial H ypertension C linical T rial (IMPA...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 476.9% to $0.75 on volume of 1,104,730,765 shares NVIDIA Corporation (NVDA) fell 0.7% to $130.98 on volume of 283,604,651 shares ENDRA Life Sciences Inc. (NDRA) rose 34.2% to $0.139 on volume of 219,783,92...